|1.||Nurulain, S M: 2 articles (03/2007 - 11/2005)|
|2.||Arafat, K: 2 articles (03/2007 - 11/2005)|
|3.||Petroianu, G A: 2 articles (03/2007 - 11/2005)|
|4.||Hasan, M Y: 2 articles (03/2007 - 11/2005)|
|5.||Soyka, M: 2 articles (01/2006 - 03/2005)|
|6.||Sasaki, Hidetada: 2 articles (04/2005 - 02/2005)|
|7.||Kuehn, K U: 2 articles (03/2003 - 11/2001)|
|8.||Armbruster, J: 2 articles (03/2003 - 11/2001)|
|9.||Abraham, G: 2 articles (03/2003 - 11/2001)|
|10.||Gaensicke, M: 2 articles (03/2003 - 11/2001)|
|1.||Alcoholism (Alcohol Abuse)
04/14/1983 - "Tiapride therefore proves a highly effective therapeutic agent in chronic alcoholism, providing rapid action, good results and excellent tolerance with small dosages."
10/31/1982 - "[Tiapride and alcoholism: evaluation of its therapeutic efficacy in 80 cases of alcoholic diseases]."
12/18/1981 - "Tiapride was effective against acute manifestations of alcoholism and against agitation, especially in the elderly. "
04/18/1979 - "It is true that the product was not associated systematically with psychotherapy which might have made the results more demonstrative, but the objective of the study was to evaluate whether tiapride could be of value by assisting in the fight against alcoholism, and this was confirmed."
05/01/1977 - "[Ambulatory trial of Tiapridal in chronic alcoholism]."
12/30/1982 - "Tiapride proved effective in reducing the frequency of headache (in 65% of patients), with an improvement rate which was statistically significant in comparison to the placebo. "
05/18/1979 - "Tiapride seems more effective in early headache than in cephalalgia occuring later."
02/03/1983 - "To evaluate the effectiveness of intravenous tiapride in preventing cephalalgia following rachiocentesis, two groups of patients were studied in a double blind trial. "
10/18/1979 - "A therapeutic study was conducted by practitioners working in a group practice, to evaluate the activity of tiapride in treating headaches, over a period of 1 year. "
12/08/1978 - "The aim of this study was to try the efficiency of tiapridal in preventing headache during neuro-radiological procedures. "
10/01/1985 - "The purpose of present study was to investigate efficacy and safety of Tiapride in patients with various forms of dyskinesia in long-term treatment. "
10/01/1985 - "[Long-term evaluation of tiapride in patients with various forms of dyskinesia]."
06/01/1983 - "Tiapride in doses not accompanied by significant recurrence of Parkinsonian symptoms revealed no significant diminution of the involuntary movements, and no effect on on-off periods was found."
12/09/1982 - "Tiapride was given at an average dosage of 300-900 mg per day, intramuscularly for the first three days, then by oral route, to 62 patients with abnormal movements of various types. "
03/25/1982 - "Twenty-five patients with various forms of dyskinesia were given tiapride for three months. "
|4.||Movement Disorders (Movement Disorder)
06/01/1985 - "The symptoms of tardive dyskinesia significantly improved during treatment and deteriorated after tiapride was withdrawn. "
06/01/1985 - "Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study."
01/01/1985 - "Therefore, more dyskinetic patients have to be evaluated in long-term studies with tiapride, before this drug could be recommended in tardive dyskinesia, when dyskinetic movements become intolerable."
06/01/2003 - "However, in elderly patients with movement disorders tiapride treatment is associated with markedly increased platelet counts."
06/01/2003 - "To characterize tiapride's potential to increase platelet counts in healthy subjects and patients with movement disorders. "
|5.||Psychomotor Agitation (Akathisia)
01/01/1997 - "Measuring the efficacy of psychopharmacological treatment of psychomotoric restlessness in dementia: clinical evaluation of tiapride."
03/25/1982 - "No instances of tiapride-induced dyskinesia or akathisia were seen. "
01/01/1998 - "In that study, tiapride as a drop formulation compared with melperone was safe and effective with regard to restlessness and aggressive behaviour in elderly patients."
01/01/1984 - "The psychomotor agitation caused by ketamine is counteracted by the doses of tiapride used. "
|7.||Antipsychotic Agents (Antipsychotics)
|2.||Drug Therapy (Chemotherapy)